ATE369340T1 - Verfahren zur herstellung eines multiform- kristalls von donepezil hydrochlorid - Google Patents

Verfahren zur herstellung eines multiform- kristalls von donepezil hydrochlorid

Info

Publication number
ATE369340T1
ATE369340T1 AT01965676T AT01965676T ATE369340T1 AT E369340 T1 ATE369340 T1 AT E369340T1 AT 01965676 T AT01965676 T AT 01965676T AT 01965676 T AT01965676 T AT 01965676T AT E369340 T1 ATE369340 T1 AT E369340T1
Authority
AT
Austria
Prior art keywords
producing
donepezil hydrochloride
ylümethylpiperidine
indanon
dimethoxy
Prior art date
Application number
AT01965676T
Other languages
English (en)
Inventor
Akio Imai
Akihiko Shimotani
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE369340T1 publication Critical patent/ATE369340T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT01965676T 2000-09-25 2001-09-17 Verfahren zur herstellung eines multiform- kristalls von donepezil hydrochlorid ATE369340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000289956 2000-09-25
JP2000322184 2000-10-23

Publications (1)

Publication Number Publication Date
ATE369340T1 true ATE369340T1 (de) 2007-08-15

Family

ID=26600625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01965676T ATE369340T1 (de) 2000-09-25 2001-09-17 Verfahren zur herstellung eines multiform- kristalls von donepezil hydrochlorid

Country Status (9)

Country Link
US (2) US20040034057A1 (de)
EP (1) EP1323712B1 (de)
JP (1) JPWO2002026709A1 (de)
AT (1) ATE369340T1 (de)
AU (1) AU2001286260A1 (de)
DE (1) DE60129828T2 (de)
ES (1) ES2288984T3 (de)
IL (2) IL154711A0 (de)
WO (1) WO2002026709A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4521682B2 (ja) * 2002-07-24 2010-08-11 佐竹化学機械工業株式会社 晶析装置の結晶粒度制御装置
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
WO2004092137A1 (en) * 2003-04-16 2004-10-28 Hetero Drugs Limited Novel crystalline forms of donepezil hydrochloride
JP4748449B2 (ja) * 2003-11-27 2011-08-17 味の素株式会社 フェニルアラニン誘導体の結晶及びその製造方法
US20070123565A1 (en) * 2004-07-23 2007-05-31 Aher Umesh P Donepezil Hydrochloride Form VI
EP1771416A1 (de) * 2004-07-28 2007-04-11 USV Limited Neuer polymorph von (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidinhydrochlorid (donepezilhydrochlorid) und verfahren zu dessen herstellung
WO2006035433A2 (en) * 2004-09-29 2006-04-06 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
US20060122226A1 (en) 2004-12-08 2006-06-08 Itai Adin Crystalline forms of Donepezil base
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
WO2009084030A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd. Improved process for the preparation of (1-benzyl-4-(5,6,- dimethoxyind anone-2-yl)methylpiperidine) hydrochloride-form iii
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
WO2011061591A1 (en) * 2009-11-18 2011-05-26 Jubilant Life Sciences Limited Improved process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanone)-2-yl)methyl piperidine hydrochloride form-iii
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
CN117554528A (zh) * 2023-12-18 2024-02-13 南通联亚药业股份有限公司 一种盐酸美金刚多奈哌齐药物中盐酸美金刚和多奈哌齐的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046526A1 (en) * 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
TW513409B (en) * 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride

Also Published As

Publication number Publication date
EP1323712A4 (de) 2004-07-21
US20040034057A1 (en) 2004-02-19
WO2002026709A1 (en) 2002-04-04
IL154711A (en) 2009-05-04
JPWO2002026709A1 (ja) 2004-02-05
EP1323712B1 (de) 2007-08-08
EP1323712A1 (de) 2003-07-02
IL154711A0 (en) 2003-10-31
ES2288984T3 (es) 2008-02-01
US7479563B2 (en) 2009-01-20
DE60129828T2 (de) 2008-04-30
AU2001286260A1 (en) 2002-04-08
DE60129828D1 (de) 2007-09-20
US20050209281A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
ATE369340T1 (de) Verfahren zur herstellung eines multiform- kristalls von donepezil hydrochlorid
ATE248148T1 (de) Verfahren zur herstellung von levobupivacaine und analoge
ATE348814T1 (de) Verfahren zur herstellung von chinolinderivaten
ATE477238T1 (de) Verfahren zur herstellung von dithioestern
FI904035A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
PT87294A (pt) Process for the preparation of 17beta-(cyclopropylamino)-androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors and of pharmaceutical compositions containing the same
EP1327626A4 (de) Verfahren zur reinigung von plavastatin
DE69907656D1 (de) Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung
ATE244263T1 (de) Verfahren zur herstellung von n-glycyltyrosin
ATE152709T1 (de) Tetrahydrocyclopent(b>indole-methanamine und verwandte verbindungen, und verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
DE50306068D1 (de) Verfahren zum herstellen von salzen des tolperison
DE50003759D1 (de) Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
ATE434611T1 (de) Verfahren zur herstellung von estern der amicsäure
ATE195115T1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten
ATE228512T1 (de) Verfahren zur herstellung von 3-isochromanonen durch cyclisierung von o- chlormehtylphenylessigsäuren
ATE188211T1 (de) Cyclopropyl-derivate, verfahren zur herstellung und anwendungen
ATE517870T1 (de) Verfahren zur herstellung von alpha- aminosubstituierten carbonsäureamiden
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
ATE312071T1 (de) Verfahren zur herstellung von vanillylamin hydrochlorid
DE69819315D1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE260922T1 (de) Verfahren und zwischenprodukte zur herstellung von 5,7-dihydro-3-(2 1-benzylpiperidin-4-yl
ATE407118T1 (de) Verfahren zur herstellung von n-alkoxycarbonyl- piperidin derivaten sowie zwischenverbindungen dafür
Bymaster et al. 3-hexyloxy analogs of TZTP are potent and selective M1 agonists in brain of rat in vivo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties